Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(4-Fluorophenyl)butanoic acid, also known as 4-fluoro-α-methylphenylbutyric acid, is a chemical compound with the molecular formula C10H11FO2. It is a derivative of butanoic acid and contains a fluorine-substituted phenyl group. 4-(4-Fluorophenyl)butanoic acid is characterized by its potential applications in the pharmaceutical industry and its unique structural features that contribute to its properties and uses.

589-06-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 589-06-0 Structure
  • Basic information

    1. Product Name: 4-(4-Fluorophenyl)butanoic acid
    2. Synonyms: TIMTEC-BB SBB010216;CHEMBRDG-BB 4002813;4-(4-FLUOROPHENYL)BUTYRIC ACID;4-(p-fluorophenyl)butyric acid;4-(4-Fluorophenyl)butanoic acid;4-Fluorobenzenebutanoic acid;Benzenebutanoic acid, 4-fluoro-
    3. CAS NO:589-06-0
    4. Molecular Formula: C10H11FO2
    5. Molecular Weight: 182.19
    6. EINECS: 209-631-8
    7. Product Categories: Aliphatics;Carboxylic Acids;Carboxylic Acids;Aromatic Building Blocks
    8. Mol File: 589-06-0.mol
  • Chemical Properties

    1. Melting Point: 45 °C
    2. Boiling Point: 296.5°C at 760mmHg
    3. Flash Point: 133.1°C
    4. Appearance: /
    5. Density: 1.182g/cm3
    6. Vapor Pressure: 0.000646mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. PKA: 4.75±0.10(Predicted)
    11. CAS DataBase Reference: 4-(4-Fluorophenyl)butanoic acid(CAS DataBase Reference)
    12. NIST Chemistry Reference: 4-(4-Fluorophenyl)butanoic acid(589-06-0)
    13. EPA Substance Registry System: 4-(4-Fluorophenyl)butanoic acid(589-06-0)
  • Safety Data

    1. Hazard Codes: C,Xi,Xn
    2. Statements: 22-41
    3. Safety Statements: 26-39
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 589-06-0(Hazardous Substances Data)

589-06-0 Usage

Uses

Used in Pharmaceutical Industry:
4-(4-Fluorophenyl)butanoic acid is used as a chemical intermediate for the synthesis of various compounds, including medications and research chemicals. Its unique structure allows for the development of new drugs and the study of their effects on the body.
Used in Antidepressant Research:
4-(4-Fluorophenyl)butanoic acid is used as a potential antidepressant, contributing to research and development in the medical field. Its properties may help in the discovery and understanding of new treatments for depression.
Used in Anticonvulsant Research:
4-(4-Fluorophenyl)butanoic acid is also used as a potential anticonvulsant, making it an important compound for research in the field of epilepsy and seizure disorders. Its potential to treat these conditions is a significant area of study in medical research.

Check Digit Verification of cas no

The CAS Registry Mumber 589-06-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 589-06:
(5*5)+(4*8)+(3*9)+(2*0)+(1*6)=90
90 % 10 = 0
So 589-06-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H11FO2/c11-9-6-4-8(5-7-9)2-1-3-10(12)13/h4-7H,1-3H2,(H,12,13)/p-1

589-06-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H26035)  4-(4-Fluorophenyl)butyric acid, 97%   

  • 589-06-0

  • 250mg

  • 359.0CNY

  • Detail
  • Alfa Aesar

  • (H26035)  4-(4-Fluorophenyl)butyric acid, 97%   

  • 589-06-0

  • 1g

  • 1014.0CNY

  • Detail

589-06-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-Fluorophenyl)butanoic acid

1.2 Other means of identification

Product number -
Other names 4-(4-fluorophenyl)butanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:589-06-0 SDS

589-06-0Relevant articles and documents

Practical Synthesis of (3a R, 9b R)-8-Fluoro-7-(perfluoropropan-2-yl)-9b-(phenylsulfonyl)-2,3,3a,4,5,9b-hexahydro-1 H-benzo[e]indole: An Advanced Intermediate to Access the RORγt Inverse Agonist BMT-362265

Karmakar, Ananta,Nimje, Roshan Y.,Silamkoti, Arundutt,Pitchai, Manivel,Basha, Mushkin,Singarayer, Christuraj,Ramasamy, Duraisamy,Babu, G. T. Venkatesh,Samikannu, Ramesh,Subramaniam, Srinath,Anjanappa, Prakash,Vetrichelvan, Muthalagu,Kumar, Hemantha,Dikundwar, Amol G.,Gupta, Anuradha,Gupta, Arun Kumar,Rampulla, Richard,Dhar, T. G. Murali,Mathur, Arvind

, p. 1001 - 1014 (2021/04/12)

A practical and scalable route to (3aR, 9bR)-8-fluoro-7-(perfluoropropan-2-yl)-9b-(phenylsulfonyl)-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole 10, an advanced intermediate en route to the synthesis of the RORγt inverse agonist, BMT-362265, is described starting from fluorobenzene. The synthesis involved the screening of multiple synthetic routes for their feasibility and scalability. We also demonstrate the utility of an annulating reagent, (R)-N-(2-chloroethyl)-2-methylpropane-2-sulfinamide, for the diastereoselective synthesis of tricyclic pyrrolidine intermediates 24 and 36 on a multigram scale.

Synthesis of Enantiopure ω-(4-Fluorophenyl)-6,11-Methylene Lipoxin B 4Methyl Ester

Trippe, Lukas,Nava, Analuisa,Frank, Andrea,Schollmeyer, Dieter,Nubbemeyer, Udo

supporting information, p. 3760 - 3768 (2021/06/28)

The synthesis of Lipoxin B 4analogues (LXB 4) to gain access to stabilized inflammation-resolving compounds is an active field of research. Focusing on variation and stabilization of the conjugated E, Z, E, E C6-C13 tetraene moiety of natural LXB 4, a methylene bridge introduced between C6 and C11 suppresses any Z / E isomerization of the C8-C9 olefin. Furthermore, rapid ω-oxidation (C20) should be avoided by replacing the C18-C20 segment by an aromatic moiety. Optically active C1-C12 building blocks were accessed from methyl cycloheptatriene-1-carboxylate (C6-C11, C21) and glutaryl chloride (C1-C5) as described earlier. The ω-segment was generated via a five-step sequence starting from 4-arylbutanoic acid. Horner key olefination enabled assembly of the carbon backbone. A final five-step sequence including a chelate Cram reduction of the unsaturated ketone moiety afforded the target ω-aryl 6,11-methylene-LXB 4methyl ester.

Ligand-Controlled Regiodivergence in Nickel-Catalyzed Hydroarylation and Hydroalkenylation of Alkenyl Carboxylic Acids**

Deng, Ruohan,Engle, Keary M.,Fu, Yue,Gao, Yang,Li, Zi-Qi,Liu, Peng,Tran, Van T.

supporting information, p. 23306 - 23312 (2020/10/19)

A nickel-catalyzed regiodivergent hydroarylation and hydroalkenylation of unactivated alkenyl carboxylic acids is reported, whereby the ligand environment around the metal center dictates the regiochemical outcome. Markovnikov hydrofunctionalization products are obtained under mild ligand-free conditions, with up to 99 % yield and >20:1 selectivity. Alternatively, anti-Markovnikov products can be accessed with a novel 4,4-disubstituted Pyrox ligand in excellent yield and >20:1 selectivity. Both electronic and steric effects on the ligand contribute to the high yield and selectivity. Mechanistic studies suggest a change in the turnover-limiting and selectivity-determining step induced by the optimal ligand. DFT calculations reveal that in the anti-Markovnikov pathway, repulsion between the ligand and the alkyl group is minimized (by virtue of it being 1° versus 2°) in the rate- and regioselectivity-determining transmetalation transition state.

Synthesis of Novel Pterocarpen Analogues via [3?+?2] Coupling-Elimination Cascade of α,α-Dicyanoolefins with Quinone Monoimines

Chen, Hui,Zhao, Sihan,Cheng, Shaobing,Dai, Xingjie,Xu, Xiaoying,Yuan, Weicheng,Zhang, Xiaomei

, p. 1672 - 1683 (2019/04/08)

By employing triethylamine as a catalyst, [3?+?2] coupling-elimination cascade of α,α-dicyanoolefins with quinone monoimines was realized. The reactions afforded various novel pterocarpen analogues with generally moderate yields (up to 75%). In addition, a plausible reaction mechanism was proposed.

Cooperative iodine and photoredox catalysis for direct oxidative lactonization of carboxylic acids

Duhamel, Thomas,Mu?iz, Kilian

, p. 933 - 936 (2019/01/23)

A new method for the formation of γ- and δ-lactones from carboxylic acids through direct conversion of benzylic C-H to C-O bonds is described. The reaction is conveniently induced by visible light and relies on a mild cooperative catalysis by the combination of molecular iodine and an organic dye.

Visible-light-induced oxidation/[3 + 2] cycloaddition/oxidative aromatization to construct benzo[ a]carbazoles from 1,2,3,4-tetrahydronaphthalene and arylhydrazine hydrochlorides

Shen, Jiaxuan,Li, Nannan,Yu, Yanjiang,Ma, Chunhua

, p. 7179 - 7183 (2019/09/30)

An efficient synthesis of benzo[a]carbazoles via visible-light-induced tandem oxidation/[3 + 2] cycloaddition/oxidative aromatization reactions was reported. The benzylic C(sp3)-H of tetrahydronaphthalene was activated through visible-light photoredox catalyst with oxygen as the clean oxidant under mild reaction conditions. This protocol proceeds efficiently with broad substrate scope, and the mechanism study was performed.

Strategic Approach to the Metamorphosis of γ-Lactones to NH γ-Lactams via Reductive Cleavage and C-H Amidation

Jung, Hoi-Yun,Chang, Sukbok,Hong, Sungwoo

supporting information, p. 7099 - 7103 (2019/09/07)

A new approach has elaborated on the conversion of γ-lactones to the corresponding NH γ-lactams that can serve as γ-lactone bioisosteres. This approach consists of reductive C-O cleavage and an Ir-catalyzed C-H amidation, offering a powerful synthetic tool for accessing a wide range of valuable NH γ-lactam building blocks starting from γ-lactones. The synthetic utility was further demonstrated by the late-stage transformation of complex bioactive molecules and the asymmetric transformation.

Metal-Free Enantioselective Oxidative Arylation of Alkenes: Hypervalent-Iodine-Promoted Oxidative C?C Bond Formation

Shimogaki, Mio,Fujita, Morifumi,Sugimura, Takashi

supporting information, p. 15797 - 15801 (2016/12/16)

The enantioselective oxyarylation of (E)-6-aryl-1-silyloxylhex-3-ene was achieved using a lactate-based chiral hypervalent iodine(III) reagent in the presence of boron trifluoride diethyl etherate. The silyl ether promotes the oxidative cyclization, and enhances the enantioselectivity. In addition, the corresponding aminoarylation was achieved.

Highly enantioselective [3+2] coupling of cyclic enamides with quinone monoimines promoted by a chiral phosphoric acid

Zhang, Minmin,Yu, Shuowen,Hu, Fangzhi,Liao, Yijun,Liao, Lihua,Xu, Xiaoying,Yuan, Weicheng,Zhang, Xiaomei

, p. 8757 - 8760 (2016/07/15)

Enantioselective [3+2] coupling of cyclic enamides with quinone monoimines was realised using a chiral phosphoric acid as a catalyst. This transformation allowed for the synthesis of highly enantioenriched polycyclic 2,3-dihydrobenzofurans (up to 99.9% ee). The absolute configuration of one product was determined by an X-ray crystal structural analysis. We also found a possible mechanism for this reaction.

INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS)

-

Page/Page column 98, (2015/09/28)

A series of phenelzine analogs comprising a phenelzine scaffold linked to an aromatic moiety and their use as inhibitors of lysine-specific demethylase 1 (LSD1) and/or one or more histone deacetylases (HDACs) is provided. The presently disclosed phenelzine analogs exhibit potency and selectivity for LSD1 versus MAO and LSD2 enzymes and exhibit bulk, as well as, gene specific histone methylation changes, anti-proliferative activity in several cancer cell lines, and neuroprotection in response to oxidative stress. Accordingly, the presently disclosed phenelzine analogs can be used to treat diseases, conditions, or disorders related to LSD1 and/or HDACs, including, but not limited to, cancers and neurodegenerative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 589-06-0